4.6 Article

Comparing Pooled Peptides with Intact Protein for Accessing Cross-presentation Pathways for Protective CD8+ and CD4+ T Cells

Related references

Note: Only part of the references are listed.
Review Oncology

Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines

Cornelis J. M. Melief et al.

NATURE REVIEWS CANCER (2008)

Article Multidisciplinary Sciences

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

Amanda L. Gavin et al.

SCIENCE (2006)

Article Immunology

Overlapping synthetic peptides as vaccines

Shisong Jiang et al.

VACCINE (2006)

Article Multidisciplinary Sciences

Control of B-cell responses by Toll-like receptors

C Pasare et al.

NATURE (2005)

Review Immunology

Mechanisms of MHC class I-restricted antigen processing and cross-presentation

P Cresswell et al.

IMMUNOLOGICAL REVIEWS (2005)

Article Biochemistry & Molecular Biology

Targeting the innate immune response with improved vaccine adjuvants

A Pashine et al.

NATURE MEDICINE (2005)

Article Multidisciplinary Sciences

CD8+T cell cross-priming via transfer of proteasome substrates

CC Norbury et al.

SCIENCE (2004)

Article Immunology

Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A

M Martin et al.

INFECTION AND IMMUNITY (2003)

Article Biochemistry & Molecular Biology

Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages

E Gagnon et al.

Article Multidisciplinary Sciences

Decoding the patterns of self and nonself by the innate immune system

R Medzhitov et al.

SCIENCE (2002)